I agree that this site is using cookies. You can find further informations here.
X
Deblina Raychaudhuri
28  results:
Search for persons X
?
1

Circulating Interleukin-8 Dynamics Parallels Disease Course..:

D'Rozario, Ranit ; Raychaudhuri, Deblina ; Bandopadhyay, Purbita...
Viruses.  15 (2023)  2 - p. 549 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Immune checkpoint therapy—current perspectives and future d..:

Sharma, Padmanee ; Goswami, Sangeeta ; Raychaudhuri, Deblina...
Cell.  186 (2023)  8 - p. 1652-1669 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Myeloid-specific KDM6B inhibition sensitizes glioblastoma t..:

Goswami, Sangeeta ; Raychaudhuri, Deblina ; Singh, Pratishtha...
Nature Cancer.  4 (2023)  10 - p. 1455-1473 , 2023
Link: https://doi.org/10.1038/..
 
?
4

A phase 2 single center open label randomised control trial..:

Ray, Yogiraj ; Paul, Shekhar Ranjan ; Bandopadhyay, Purbita...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
5

Clinical Trial Subgroup Analyses to Investigate Clinical an..:

Raychaudhuri, Deblina ; Bandopadhyay, Purbita ; D'Rozario, Ranit...
Mayo Clinic Proceedings: Innovations, Quality & Outcomes.  6 (2022)  6 - p. 511-524 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Myeloid cell-targeted therapies for solid tumours:

Goswami, Sangeeta ; Anandhan, Swetha ; Raychaudhuri, Deblina.
Nature Reviews Immunology.  23 (2022)  2 - p. 106-120 , 2022
Link: https://doi.org/10.1038/..
 
?
7

Plasma Gradient of Soluble Urokinase-Type Plasminogen Activ..:

Sarif, Jafar ; Raychaudhuri, Deblina ; D'Rozario, Ranit...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
8

Systematic Optimization of Potent and Orally Bioavailable P..:

Kundu, Biswajit ; Raychaudhuri, Deblina ; Mukherjee, Ayan...
Journal of Medicinal Chemistry.  64 (2021)  13 - p. 9279-9301 , 2021
Link: https://doi.org/10.1021/..
 
?
9

Role of Ca2+ in toll-like receptor 9 activation in human pl..:

Raychaudhuri, Deblina ; Duttagupta, Pritam ; Liu, Chinky Shiu Chen...
Cytokine.  125 (2020)  - p. 154822 , 2020
Link: https://doi.org/10.1016/..
 
?
10

A Chemical Switch for Transforming a Purine Agonist for Tol..:

Mukherjee, Ayan ; Raychaudhuri, Deblina ; Sinha, Bishnu Prasad...
Journal of Medicinal Chemistry.  63 (2020)  9 - p. 4776-4789 , 2020
Link: https://doi.org/10.1021/..
 
?
11

Lactate Induces Pro-tumor Reprogramming in Intratumoral Pla..:

Raychaudhuri, Deblina ; Bhattacharya, Roopkatha ; Sinha, Bishnu Prasad...
Frontiers in Immunology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
12

Activity-guided development of potent and selective toll-li..:

Paul, Barnali ; Rahaman, Oindrila ; Roy, Swarnali...
European Journal of Medicinal Chemistry.  159 (2018)  - p. 187-205 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Circulating Interleukin-8 Dynamics Parallels Disease Course..:

Ranit D'Rozario ; Deblina Raychaudhuri ; Purbita Bandopadhyay...
https://www.mdpi.com/1999-4915/15/2/549.  , 2023
Link: https://doi.org/10.3390/..
 
?
14

Circulating Interleukin-8 Dynamics Parallels Disease Course..:

Ranit D'Rozario ; Deblina Raychaudhuri ; Purbita Bandopadhyay...
SARS-CoV-2 and COVID-19.  , 2023
Link: https://doi.org/10.3390/..
 
?
15

A phase 2 single center open label randomised control trial..:

Yogiraj Ray ; Shekhar Ranjan Paul ; Purbita Bandopadhyay...
https://doi.org/10.1038/s41467-022-28064-7.  , 2022
Link: https://doi.org/10.1038/..
 
1-15